OBR Green Articles (ASCO Conference Coverage)

article

June 2018Edition

Can many women with early-stage breast cancer avoid chemotherapy and kidney cancer patients bypass surgery? New standards-of-care and possibly less radical treatment for patients was a key take-away from ASCO’s plenaries, where breakthroughs in fi...

article

June 2018Edition

Tumor-agnostic trials, with cancer location taking a backseat to genetics, marks a new age in precision medicine. Two of the most exciting studies at ASCO looked at RET-fusion positive cancers with LOXO-292 and paired treatments with patients' rare c...

article

June 2018Edition

The enthusiasm for the new CAR-Ts Kymriah and Yescarta has been dampened by limited patient access and uncertainties about cost and reimbursement. As CMS and other payers grapple with coverage decisions, the long-term economic sustainability of these...